Project Details
Description
Primary hyperparathyroidism (HPT), a common endocrine disorder that can
cause significant morbidity, may be due to benign neoplasia of a single
parathyroid gland (adenoma) or multiple parathyroid glands (hyperplasia),
and rarely, to malignant neoplasia of a parathyroid gland (carcinoma).
The etiology of parathyroid neoplasia has not been defined. As with
other forms of neoplasia, parathyroid tumors are presumably due to
inherited (germ-line mutation) and/or acquired (somatic mutation) defects
in specific genes. Etiologic genetic defects could include inappropriate
expression of transforming "oncogenes" and/or loss of expression of tumor
"suppressor" genes. The availability of surgically resected parathyroid
tumors from patients with sporadic and hereditary forms of disease allows
us to search for tumor-specific genetic abnormalities that may be
involved in development of parathyroid neoplasia.
Status | Not started |
---|
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.